Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-20

FDA Approved: TRIENTINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a generic version of trientine hydrochloride from Rising Pharma Holdings, Inc. for the treatment of Wilson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIENTINE HYDROCHLORIDE (Trientine hydrochloride)

Snippet

ORIG AP for TRIENTINE HYDROCHLORIDE (TRIENTINE HYDROCHLORIDE)